August 6, 2010 -- The Scientific American, impressed by the vibrancy of China’s biopharma innovation, devoted a special section to the sector. The magazine was especially impressed by the improvement in China’s IP protection, which has historically been a sore spot for foreigners. SciAm’s China section accompanied the second annual appearance of the magazine’s Worldview Scorecard, an index of factors that rank countries on their potential for biopharma success. More details...
